Al Janaby T, Khelwatty S, Bagwan I, Abbassi-Ghadi N, Modjtahedi H. Co-expression of HER2/EGFRvIII/CD44 and Claudin 18.2/CD109 as Novel Prognostic Indicators in Stomach Adenocarcinoma. World J Oncol. 2025;16(3):254-268. doi:10.14740/wjon2552